JPWO2020001640A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020001640A5
JPWO2020001640A5 JP2020572820A JP2020572820A JPWO2020001640A5 JP WO2020001640 A5 JPWO2020001640 A5 JP WO2020001640A5 JP 2020572820 A JP2020572820 A JP 2020572820A JP 2020572820 A JP2020572820 A JP 2020572820A JP WO2020001640 A5 JPWO2020001640 A5 JP WO2020001640A5
Authority
JP
Japan
Prior art keywords
diacid
mannurone
total weight
pharmaceutical composition
mannuron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020572820A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021528460A (ja
JP2021528460A5 (https=
Publication date
Priority claimed from CN201810713411.3A external-priority patent/CN110652516A/zh
Application filed filed Critical
Publication of JP2021528460A publication Critical patent/JP2021528460A/ja
Publication of JP2021528460A5 publication Critical patent/JP2021528460A5/ja
Publication of JPWO2020001640A5 publication Critical patent/JPWO2020001640A5/ja
Pending legal-status Critical Current

Links

JP2020572820A 2018-06-29 2019-06-28 パーキンソン病の治療におけるマンヌロン二酸組成物の使用 Pending JP2021528460A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201810713411.3A CN110652516A (zh) 2018-06-29 2018-06-29 甘露糖醛二酸的组合物在治疗帕金森氏症中的应用
CN201810713411.3 2018-06-29
PCT/CN2019/093803 WO2020001640A1 (zh) 2018-06-29 2019-06-28 甘露糖醛二酸的组合物在治疗帕金森氏症中的应用

Publications (3)

Publication Number Publication Date
JP2021528460A JP2021528460A (ja) 2021-10-21
JP2021528460A5 JP2021528460A5 (https=) 2022-07-05
JPWO2020001640A5 true JPWO2020001640A5 (https=) 2022-07-05

Family

ID=68984646

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020572820A Pending JP2021528460A (ja) 2018-06-29 2019-06-28 パーキンソン病の治療におけるマンヌロン二酸組成物の使用

Country Status (7)

Country Link
US (1) US11406654B2 (https=)
EP (1) EP3815691A4 (https=)
JP (1) JP2021528460A (https=)
KR (1) KR20210038874A (https=)
CN (1) CN110652516A (https=)
AU (1) AU2019296851A1 (https=)
WO (1) WO2020001640A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114796243B (zh) * 2021-01-27 2024-04-05 中国海洋大学 一种甘露糖醛酸和益母草碱的药物组合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1562050A (zh) * 2004-03-24 2005-01-12 中国海洋大学 褐藻酸寡糖在抗痴呆、抗糖尿病中的应用
CN101301310B (zh) * 2007-05-08 2011-11-02 首都医科大学 褐藻多糖硫酸酯在预防和治疗帕金森病中的用途
US20140371283A1 (en) * 2013-02-12 2014-12-18 Buck Institute For Research On Aging Hydantoins that modulate bace-mediated app processing
CN103405468B (zh) * 2013-08-16 2015-08-19 中国海洋大学 一种低分子量甘露糖醛酸寡糖在制备预防或治疗帕金森症的药物或保健品中的应用
CN103800348B (zh) * 2014-03-13 2015-07-01 中国科学院海洋研究所 甘露葡萄糖醛酸寡糖在制备治疗或预防帕金森病和/或老年痴呆药物和/或保健品中的应用
CN103948611B (zh) * 2014-03-31 2016-03-02 青岛海洋生物医药研究院股份有限公司 低聚古罗糖醛酸盐在制备防治帕金森症药物或制品中的应用
CN106344592A (zh) * 2015-07-17 2017-01-25 上海绿谷制药有限公司 还原端1位为羧基的甘露糖醛酸寡糖及其衍生物在治疗帕金森氏症中的应用
JP6977059B2 (ja) * 2016-12-30 2021-12-08 シャンハイ、グリーン、バレー、ファーマスーティカル、カンパニー、リミテッドShanghai Green Valley Pharmaceutical Co., Ltd. マンヌロン二酸の組成物

Similar Documents

Publication Publication Date Title
JP6214750B2 (ja) 低用量トピラメート／フェンテルミン組成物およびその使用方法
US20260069546A1 (en) Low dose topiramate/phentermine composition and methods of use thereof
EP1496917B1 (en) Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
RS20080181A (sr) Čvrste farmaceutske kompozicije koje sadrže pregabalin sredstvo za formiranje matriksa i sredstvo za bubrenje
JP2024164167A5 (https=)
JP2013515009A5 (https=)
CN1602198A (zh) 用于眼科和鼻科的药物组合物
EP2034956B2 (en) Compositions comprising glycosaminoglycans of low viscosity and use of said composition in therapy of chronic cystitis
JPWO1993013781A1 (ja) コレステロール低下剤
WO2008014685A1 (fr) Formulation contenant du tréhalose à des fins d'injection intraarticulaire
JP2011037849A (ja) 消化性潰瘍及び十二指腸潰瘍の治療及び予防に使用されるヒアルロン酸混合物
JP2021529195A5 (https=)
JPWO2020001640A5 (https=)
JP2021528460A5 (https=)
JPWO2020001644A5 (https=)
JPWO2020001643A5 (https=)
JP2021528459A5 (https=)
JPWO2020001611A5 (https=)
US20130023575A1 (en) Compositions and methods for the treatment of ocular surface allergies
JP2021528458A5 (https=)
US20060058261A1 (en) Chitin derivatives for hyperlipidemia
JP2021529196A5 (https=)
JP4845353B2 (ja) 陰イオン交換樹脂を含む医薬組成物
JPWO2020001639A5 (https=)
AU2016203698B2 (en) Low Dose Topiramate/Phentermine Composition and Methods of Use Thereof